Skip to main content
Gustavo Heresi Davila, MD, Pulmonology, Cleveland, OH

Gustavo Adolfo Heresi Davila MD

Critical Care Medicine, Pleural Disease


Physician

Join to view full profile
  • 9500 Euclid AveA 90Cleveland, OH 44195

  • Phone+1 216-444-4707

  • Fax+1 216-445-8160

Dr. Heresi Davila is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Pulmonary Disease and Critical Care Medicine, 2008
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 2005
  • National University of St. Augustin of Arequipa - Faculty of Medicine
    National University of St. Augustin of Arequipa - Faculty of MedicineClass of 2000

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2008 - 2028
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2014, 2016-2017

Publications & Presentations

PubMed

Press Mentions

  • Treating Chronic Thromboembolic Pulmonary Hypertension
    Treating Chronic Thromboembolic Pulmonary HypertensionJune 3rd, 2025

Grant Support

  • 1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial HypertensionCLEVELAND CLINIC LERNER COM-CWRU2024–2030
  • 1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial HypertensionCLEVELAND CLINIC LERNER COM-CWRU2024–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: